BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ninsontia C, Pongjit K, Chaotham C, Chanvorachote P. Silymarin selectively protects human renal cells from cisplatin-induced cell death. Pharm Biol 2011;49:1082-90. [PMID: 21591838 DOI: 10.3109/13880209.2011.568506] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Ghodousi M, Karbasforooshan H, Arabi L, Elyasi S. Silymarin as a preventive or therapeutic measure for chemotherapy and radiotherapy-induced adverse reactions: a comprehensive review of preclinical and clinical data. Eur J Clin Pharmacol 2022. [DOI: 10.1007/s00228-022-03434-8] [Reference Citation Analysis]
2 Loren P, Lugones Y, Saavedra N, Saavedra K, Páez I, Rodriguez N, Moriel P, Salazar LA. MicroRNAs Involved in Intrinsic Apoptotic Pathway during Cisplatin-Induced Nephrotoxicity: Potential Use of Natural Products against DDP-Induced Apoptosis. Biomolecules 2022;12:1206. [DOI: 10.3390/biom12091206] [Reference Citation Analysis]
3 Fang CY, Lou DY, Zhou LQ, Wang JC, Yang B, He QJ, Wang JJ, Weng QJ. Natural products: potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacol Sin 2021;42:1951-69. [PMID: 33750909 DOI: 10.1038/s41401-021-00620-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 50] [Article Influence: 41.0] [Reference Citation Analysis]
4 Asgharpour M, Alirezaei A. Herbal antioxidants in dialysis patients: a review of potential mechanisms and medical implications. Ren Fail 2021;43:351-61. [PMID: 33593237 DOI: 10.1080/0886022X.2021.1880939] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
5 Ommati MM, Farshad O, Azarpira N, Ghazanfari E, Niknahad H, Heidari R. Silymarin mitigates bile duct obstruction-induced cholemic nephropathy. Naunyn Schmiedebergs Arch Pharmacol 2021;394:1301-14. [PMID: 33538845 DOI: 10.1007/s00210-020-02040-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang X, Zhang Z, Wu SC. Health Benefits of Silybum marianum: Phytochemistry, Pharmacology, and Applications. J Agric Food Chem 2020;68:11644-64. [PMID: 33045827 DOI: 10.1021/acs.jafc.0c04791] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
7 de Souza Santos V, Peters B, Côco LZ, Alves GM, de Assis ALEM, Nogueira BV, Meyrelles SS, Porto ML, Vasquez EC, Campagnaro BP, Pereira TMC. Silymarin protects against radiocontrast-induced nephropathy in mice. Life Sciences 2019;228:305-15. [DOI: 10.1016/j.lfs.2019.04.061] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
8 Liakopoulos V, Roumeliotis S, Bozikas A, Eleftheriadis T, Dounousi E. Antioxidant Supplementation in Renal Replacement Therapy Patients: Is There Evidence? Oxid Med Cell Longev 2019;2019:9109473. [PMID: 30774749 DOI: 10.1155/2019/9109473] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 14.7] [Reference Citation Analysis]
9 Fanoudi S, Alavi MS, Karimi G, Hosseinzadeh H. Milk thistle (Silybum Marianum) as an antidote or a protective agent against natural or chemical toxicities: a review. Drug Chem Toxicol 2020;43:240-54. [PMID: 30033764 DOI: 10.1080/01480545.2018.1485687] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
10 Pruitt R, Lemanski A, Carroll A. Herbal supplements: Research findings and safety. The Nurse Practitioner 2018;43:32-7. [DOI: 10.1097/01.npr.0000531919.99762.85] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
11 Tlili N, Feriani A, Allagui MS, Saadoui E, Khaldi A, Nasri N. Effects of Rhus tripartitum fruit extract on CCl4-induced hepatotoxicity and cisplatin-induced nephrotoxicity in rats. Can J Physiol Pharmacol 2016;94:801-7. [PMID: 27351070 DOI: 10.1139/cjpp-2016-0029] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
12 Darvishi Khezri H, Salehifar E, Kosaryan M, Aliasgharian A, Jalali H, Hadian Amree A. Potential Effects of Silymarin and Its Flavonolignan Components in Patients with β-Thalassemia Major: A Comprehensive Review in 2015. Adv Pharmacol Sci 2016;2016:3046373. [PMID: 26997953 DOI: 10.1155/2016/3046373] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
13 Sedighifard Z, Roghani F, Bidram P, Harandi SA, Molavi S. Silymarin for the Prevention of Contrast-Induced Nephropathy: A Placebo-Controlled Clinical Trial. Int J Prev Med 2016;7:23. [PMID: 26941924 DOI: 10.4103/2008-7802.174762] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
14 Surai PF. Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives. Antioxidants (Basel) 2015;4:204-47. [PMID: 26785346 DOI: 10.3390/antiox4010204] [Cited by in Crossref: 272] [Cited by in F6Publishing: 304] [Article Influence: 38.9] [Reference Citation Analysis]
15 Dabak DO, Kocaman N. Effects of silymarin on methotrexate-induced nephrotoxicity in rats. Ren Fail 2015;37:734-9. [PMID: 25707519 DOI: 10.3109/0886022X.2015.1012984] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
16 Patel S. A Promising CAM Therapeutic For Multiple Cancers: Milk Thistle (Silybum). Emerging Bioresources with Nutraceutical and Pharmaceutical Prospects 2015. [DOI: 10.1007/978-3-319-12847-4_10] [Reference Citation Analysis]
17 Pan X, Jiang L, Zhong L, Geng C, Jia L, Liu S, Guan H, Yang G, Yao X, Piao F, Sun X. Arsenic induces apoptosis by the lysosomal-mitochondrial pathway in INS-1 cells. Environ Toxicol 2016;31:133-41. [PMID: 25077447 DOI: 10.1002/tox.22027] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
18 Domitrović R, Potočnjak I, Crnčević-orlić Ž, Škoda M. Nephroprotective activities of rosmarinic acid against cisplatin-induced kidney injury in mice. Food and Chemical Toxicology 2014;66:321-8. [DOI: 10.1016/j.fct.2014.02.002] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 6.9] [Reference Citation Analysis]
19 Sohn S, Kim SY, Kim HS, Chun Y, Han SY, Kim SH, Moon A. In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells. Toxicology Letters 2013;217:235-42. [DOI: 10.1016/j.toxlet.2012.12.015] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 6.3] [Reference Citation Analysis]